Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

0
Player Avatar predfern (79.12) Submitted: 11/6/2009 11:50:55 PM : Outperform Start Price: $16.28 BRLI Score: +2.81

fast growing clinical lab

Featured Broker Partners


Advertisement